CD274 and breast cancer: Preclinical data indicate that targeting PD‐L1‐expressing myeloid cells synergizes with RT in the control of experimental syngeneic glioblastomas (Zhang et al, 2019), drawing an interesting parallel with brain metastases from BC (Niesel et al, 2021).